Comparative in vitro activity of cefoperazone and various combinations of cefoperazone/sulbactam

This publication has 10 references indexed in Scilit:

• Resistance to ticarcillin-potassium clavulanate among clinical isolates of the family Enterobacteriaceae: role of PSE-1 beta-lactamase and high levels of TEM-1 and SHV-1 and problems with false susceptibility in disk diffusion tests
  Antimicrobial Agents and Chemotherapy, 1988
• Multiple-dose pharmacokinetics of intravenously administered cefoperazone and sulbactam when given in combination to infected, seriously ill, elderly patients
  Antimicrobial Agents and Chemotherapy, 1988
• Beta-lactamase inhibitors from laboratory to clinic
  Clinical Microbiology Reviews, 1988
• Multiple-dose pharmacokinetics and toleration of intravenously administered cefoperazone and sulbactam when given as single agents or in combination
  Antimicrobial Agents and Chemotherapy, 1988
• In vitro antimicrobial spectrum, occurrence of synergy, and recommendations for dilution susceptibility testing concentrations of the cefoperazone-sulbactam combination
  Journal of Clinical Microbiology, 1987
• Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with ampicillin and broad-spectrum penicillins against defined beta-lactamase-producing aerobic gram-negative bacilli
  Antimicrobial Agents and Chemotherapy, 1986
• Synergistic activity of cefoperazone in combination with β-lactamase inhibitors
  Journal of Antimicrobial Chemotherapy, 1981
• Inconsistency of Synergy Between the β -Lactamase Inhibitor CP-45,899 and β -Lactam Antibiotics Against Multiply Drug-Resistant Enterobacteriaceae and Pseudomonas Species
  Antimicrobial Agents and Chemotherapy, 1981
• Comparative Inhibition of β-Lactamases by Novel β-Lactam Compounds
  Antimicrobial Agents and Chemotherapy, 1979